DHG Pharmaceutical JSC (HOSE:DHG)

Market Cap	13.81T
Revenue (ttm)	4.98T
Net Income (ttm)	891.34B
Shares Out	130.75M
EPS (ttm)	6,816.87
PE Ratio	15.49
Forward PE	15.88
Dividend	10,000.00 (9.47%)
Ex-Dividend Date	May 23, 2025

Volume	48,357
Average Volume	26,168
Open	105,600
Previous Close	105,600
Day's Range	104,000 - 105,600
52-Week Range	87,000 - 114,000
Beta	0.37
RSI	61.06
Earnings Date	Jan 21, 2026

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in health food, dietary and consumer health supplements, and pharmaceuticals cosmetic products. It also exports its products. DHG Pharmaceuti...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,806
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2024, DHG Pharmaceutical JSC's revenue was 4.88 trillion, a decrease of -2.60% compared to the previous year's 5.02 trillion. Earnings were 753.55 billion, a decrease of -25.91%.